InvestorsHub Logo

ddls

05/17/22 7:47 PM

#291036 RE: srinsocal #291035

I see nowhere on the financials where they itemize sales, so how do you know sales increased on RecoveryRX?

Now what they should do if BIEL was a credible company is itemized sales like most competent companies do.

Declining Sales Cheers!~~

GetSeriousOK

05/17/22 9:44 PM

#291039 RE: srinsocal #291035

who said anything about Deferred Sales magic? it is what it is. No magic there.

And who says RecoveryRx sales are up? Up from what - where are RecoveryRx sales broken out from other sales? and in what quarter?

Are we expecting increased revenues in Q2? LOL based on the signing of new distributors?

Are doctors prescribing RecoveryRx? For what indication? What proof do we have of this?

I'm just so sick of the hype and BS. i'd like to see some concrete evidence of the statement "RecoveryRx Sales are Up."

pennytiger

05/18/22 11:39 AM

#291058 RE: srinsocal #291035

At the end of the day cash is still king, especially now with inflation running wild!

Cash: $249 Total assets:$312,114 Total liabilities: $15.3m

Don't see anything but more dilution coming, expecting this to go to .0002.
I hope it doesn't, but realistically I don't see how it doesn't, a new device hitting
the market with the market conditions being what they are. And the OEMs don't want to, or are unable to make a big push. Actipach is a great device, but it doesn't matter if people don't know about it.

BIEL simply doesn't have the money or resources!
GLTA!